Webcast CME

Basic and Clinical Immunology Webcast Series

 

Axial Spondyloarthritis Therapy - Current and Emerging

Print this Content

Release date: March 5, 2021
Expiration date: March 5, 2023

Estimated Time of Completion: 30 minutes

Description

The Basic and Clinical Immunology Webcast Series features webcasts by a faculty of experts and summarizes talks presented during the 9th Annual Basic and Clinical Immunology: Immunopathogenesis and Treatment of Immune Mediated Inflammatory Diseases and the Immunologic Basis of Wellness Symposium. Designed for busy clinicians who desire to increase their declarative and procedural knowledge on the integrated immune response, immunologic advances (pathogenesis, diagnosis, biomarkers) in key autoimmune diseases from a targeted therapy and treatment guidelines perspective, and how lifestyle and behavior affect immune response.


Axial Spondyloarthritis Therapy - Current and Emerging webcast highlights treatment recommendations for radiographic and non-radiographic axial spondyloarthritis (axSpA).

Learning Objectives

  1. Describe the current treatment recommendations for radiographic and non-radiographic axial spondyloarthritis (axSpA).
  2. Review clinical trial data on each of the currently approved treatments for axSpA.
  3. Define three controversial “hot topics” in axSpA: Why do IL-23 inhibitors not appear to be efficacious in axSpA? What is the prevalence and impact of concomitant fibromyalgia and axSpA Can immunomodulatory therapy inhibit structural damage progression in axSpA?

Target Audience

The educational activity is designed for rheumatologists, dermatologists, infectious disease, allergists, clinical immunologists, and specialists in integrative medicine, preventive medicine, wellness, primary care and other health care professionals caring for patients with immunologic diseases.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

American Board of Internal Medicine MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Your credit will be reported to the ABIM within 30 days of claiming credit.

Activity Director and Faculty

Activity Director

Leonard Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Faculty

Philip J. Mease, MD
Director of Rheumatology Research
Swedish Health Services
Seattle, WA

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty has indicated that he may have a relationship, which in the context of his presentation(s), could be perceived as a potential conflict of interest:

Philip J. Mease, MD Boehringer Ingelheim, Corrona, LLC, GlaxoSmithKline, Sun Pharmaceutical Industries Ltd. Consulting
Galapagos, Gilead Sciences, Inc., Novartis Consulting
Research / Independent Contractor
Abbvie Pharmaceuticals, Amgen, Bristol-Myers Squibb Co., Janssen, Lilly, Pfizer, UCB Consulting
Research / Independent Contractor
Teaching and Speaking

The following faculty has indicated he has no relationship which, in the context of his presentation(s), could be perceived as a potential conflict of interest:
Leonard Calabrese, DO

The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of the Internet Enduring activity from:

AbbVie, Inc.
Bristol-Myers Squibb
Janssen Scientific Affairs, LLC

The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of the Live activity from:

AbbVie, Inc.
Bristol-Myers Squibb
Janssen Scientific Affairs, LLC
Mallinckrodt Pharmaceuticals


This CME activity was produced by the Cleveland Clinic Center for Continuing Education
and Cleveland Clinic's RJ Fasenmyer Center for Clinical Immunology.